Mon–Thu 8am–4:30pm CT · Fri 8am–3pm CT
Clinical Trial · NCT06298838
Overview
This is a Single-center, diagnostic open-label prospective, pilot study in a total of 10 patients affected by Prostate cancer (PCa) with a risk of lymph node invasion (LNI) higher than 5% and candidates for a robot-assisted radical prostatectomy (RARP) with an extended pelvic lymph node dissection (ePLND) . The aim of the trial is to evaluate the feasibility and accuracy and clinical value of a novel high-resolution perioperative PET-CT-scan for intraoperative margin and lymph node invasion assessment, after 18F-PSMA injection, using histopathology as the gold standard.
Sponsor
IRCCS San Raffaele
Contacts
GIORGIO GANDAGLIA (CONTACT)
gandaglia.giorgio@hsr.it
+39 02 26438068
LUCIA DAMBROSIO (CONTACT)
dambrosio.lucia@hsr.it
ClinicalTrials.gov
NCT06298838Eligibility
Help us improve your experience